Fed Faces Tighter Path to Rate Cuts as Jobs Data Highlights Persistent Inflation Concerns Sebi Proposes Standardised Options Strike Price Norms to Address Intraday Volatility SpaceX IPO Could Surpass RecordBreaking Market Debuts A Look at Historys Biggest Listings Maines Fishing Industry Explores Free Fillet Program Amid Inflationary Pressures Asias Currencies Under Pressure as Oil Prices Surge and US Dollar Strengthens Amid Iran Tensions Tech Media Telecom Roundup Market Talks Highlight DeepSeek SoFi Trends RWAYI Q1 2026 Earnings EPS Miss Amidst Narrowed Lending Margins DORM Q1 2026 Earnings EPS Misses Estimates as Earnings Surprise Turns Negative Asana ASAN Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick RYTHM Inc RYM Q3 2022 Earnings Deep EPS Miss Reflects Ongoing Operational Challenges RAIL Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower RYAAY Q1 2026 Earnings WiderThanExpected Loss Amidst Operational Challenges Pan American Silver PAAS Advances 219 as Precious Metals Sentiment Strengthens Innovative Solutions and Support Inc ISSC Surges 456 as Momentum Builds Toward Key Resistance Sunrun RUN Surges 375 as Solar Stock Tests Key Resistance Zone Greenland Mines Ltd Warrant GRMLW Sees Modest Uptick as It Tests Resistance ACV Auctions ACVA Holds Steady Near Support as Market Awaits Direction Dow Jones at 130 Age Doesnt Dim Its Relevance for Investors TD Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher Curanex Pharmaceuticals Inc CURX Sees Modest Gain as Shares Test Key Levels ON24 Q4 2025 Earnings EPS Surges 151 Above Estimates Stock Jumps Leslies Inc LESL Q1 2026 Earnings LargerThanExpected Loss Amid Seasonal Weakness Enerflex Ltd Q1 2026 Earnings Significant EPS Beat Signals Strong Operational Performance HSDT Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter MPAA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Matson Inc MATX Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline